Mometasonfuroat
Følgende præparater indeholder indholdsstoffet Mometasonfuroat:
| Præparat | Dispenseringsform/styrke | Andre indholdsstoffer |
|---|---|---|
| Aphiahsone Glenmark Nordic | næsespray, suspension 50 mikrogram/dosis | |
| Asmanex® Twisthaler® Organon Denmark | inhalationspulver 200 mikrogram/dosis | |
| inhalationspulver 200 mikrogram/dosis | ||
| inhalationspulver 200 mikrogram/dosis | ||
| inhalationspulver 400 mikrogram/dosis | ||
| inhalationspulver 400 mikrogram/dosis | ||
| inhalationspulver 400 mikrogram/dosis | ||
| Atectura® Breezhaler® Novartis | inhalationspulver, kapsler 125+62,5 mikrogram | Indacaterol |
| inhalationspulver, kapsler 125+127,5 mikrogram | Indacaterol | |
| inhalationspulver, kapsler 125+260 mikrogram | Indacaterol | |
| Elocom Parallelimporteret | salve 1 mg/g | |
| salve 1 mg/g | ||
| kutanopløsning 0,1 % | ||
| kutanopløsning 0,1 % | ||
| kutanopløsning 1 mg/ml | ||
| Elocon® Organon Denmark | creme 0,1 % | |
| salve 0,1 % | ||
| kutanopløsning 0,1 % | ||
| Elopar Parallelimporteret | creme 1 mg/g | |
| Enerzair® Breezhaler® Novartis | inhalationspulver, kapsler 114+46+136 mikrogram | Glycopyrroniumbromid Indacaterol |
| Momenex 2care4 Generics | næsespray, suspension 50 mikrogram/dosis | |
| Momentan Parallelimporteret | creme 1 mg/g | |
| Mometason "Orion" Orion Pharma | næsespray, suspension 50 mikrogram/dosis | |
| Mometasone "Sandoz" Sandoz | næsespray, suspension 50 mikrogram/dosis | |
| Mometasonfuroat "2care4" Parallelimporteret | creme 1 mg/g | |
| Mometasonfuroat "Glenmark" Glenmark Nordic | creme 1 mg/g | |
| Mometasonfuroat "Teva" TEVA | næsespray, suspension 50 mikrogram/dosis | |
| Mometasonfuroat "Zentiva" Zentiva | næsespray, suspension 50 mikrogram/dosis | |
| Mommox® Sandoz | næsespray, suspension 50 mikrogram/dosis | |
| Nasonex® Organon Denmark | næsespray, suspension 50 mikrogram/dosis | |
| Ovison Galenica | creme 1 mg/g | |
| kutanopløsning 1 mg/g | ||
| Ovixan Parallelimporteret | creme 1 mg/g | |
| Ryaltris Orion Pharma | næsespray, suspension 25+600 mikrog./dosis | Olopatadin |
